A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Research Informatics Bookmark and Share

Division of Research Informatics

Ajay Shah, Ph.D.
Director
626-256-HOPE (4673), ext. 81967 
 
 
The Division of Research Informatics (RI) includes systems analysts, application developers/ software engineers, database administrators/architects, EDC/InTelescans group, and decision support services. The staff within RI is specially trained to focus on the information systems requirements unique to the research domain. RI combines the administrative and clinical care data collected during the normal course of patient care with protocol-specific data collected for research purposes and makes it available for use in outcome assessment and analysis.

The Division consists of three functional sections that include Clinical Research Informatics (CRI), Research Informatics Applications (RIA) and Translational Research Informatics (TRI). It also operates the Cancer Center’s Research Informatics section of the Clinical Protocol & Data Management (CPDM).
 
Research Informatics Applications
 
Srinivas Bolisetty
Director

Research Informatics Applications(RIA) seeks to employ emergent technologies and industry best practices to create integrated products that support the translational continuum. By taking an agile driven methodology, we are able to rapidly move requirements through a continuous integration pipeline - favoring frequent releases to minimize the time it takes for ideas to progress from concept to implementation while maximizing tolerance to change.

Services

  • Integrated Research Informatics Platform
  • In-house Applications
  • External Applications
  • Analysis, development, and integration of research support applications
  • Rapid Prototyping
  • Web & Mobile Development
     
In-House Applications
 
External Applications
 
 
Clinical Research Informatics (CRI)
 
Clinical Research Informatics (CRI) enables the effective and efficient execution of clinical research -- including clinical trials and outcomes research – by applying the science of information management. The key strategic goal of CRI is to build a world-class clinical research informatics infrastructure by implementing best-in-class vendor solutions where available and developing innovative solutions that give City of Hope researchers a competitive advantage. To advance this goal,CRI led the selection and implementation of the best-in-class Electronic Data Capture (EDC) solution for clinical trials with the Medidata EDC, and deployed the Clinical Research Portal business intelligence solution to help clinical researchers translate their data into decisions.
 
Services
 
  • Clinical Trials Data Capture and Management - Provide informatics solutions to manage the planning, execution, and reporting of clinical trials, such as protocol authoring, adverse event reporting, and subject enrollment
  • Observational Research Data Capture and Management - Provide electronic data capture (EDC) systems with electronic case report forms (eCRFs) or computer-scannable CRFs to capture study data, such as adverse events and tumor response
  • Clinical Research Decision Support - Transforms data into decisions using business intelligence tools to report and analyze study-related data
 
 
Translational Research Informatics Core (TRIC)
 
Translational Research Informatics (TRI) strives to empower ground breaking research from basic bench research to clinical research and back. Our goal is to provide contemporary technological solutions to nimbly and specifically support information capture, management and exchange across the Translational Research Space.
 
Our approach is to provide support and service at the individual lab level. Introducing new information technology solutions to help make gathering and visualization of experimental data more facile and at the same time, to optimize and make the process of scientific research more efficient. While our target clients are in the translational research space, we will develop, in time, an information infrastructure partnered with Clinical Research Informatics (CRI) and Bioinformatics that will spark and enable collaborations across basic and clinical research.
 
Services
 
  • Translational Research Experimental Data Capture, Management and Analyses
  • Systems and Process Analyses for Translational Research
  • Workflow/process analyses, optimization and automation.
  • Integrated inventory and sample management
 

Research Informatics

Division of Research Informatics

Ajay Shah, Ph.D.
Director
626-256-HOPE (4673), ext. 81967 
 
 
The Division of Research Informatics (RI) includes systems analysts, application developers/ software engineers, database administrators/architects, EDC/InTelescans group, and decision support services. The staff within RI is specially trained to focus on the information systems requirements unique to the research domain. RI combines the administrative and clinical care data collected during the normal course of patient care with protocol-specific data collected for research purposes and makes it available for use in outcome assessment and analysis.

The Division consists of three functional sections that include Clinical Research Informatics (CRI), Research Informatics Applications (RIA) and Translational Research Informatics (TRI). It also operates the Cancer Center’s Research Informatics section of the Clinical Protocol & Data Management (CPDM).
 
Research Informatics Applications
 
Srinivas Bolisetty
Director

Research Informatics Applications(RIA) seeks to employ emergent technologies and industry best practices to create integrated products that support the translational continuum. By taking an agile driven methodology, we are able to rapidly move requirements through a continuous integration pipeline - favoring frequent releases to minimize the time it takes for ideas to progress from concept to implementation while maximizing tolerance to change.

Services

  • Integrated Research Informatics Platform
  • In-house Applications
  • External Applications
  • Analysis, development, and integration of research support applications
  • Rapid Prototyping
  • Web & Mobile Development
     
In-House Applications
 
External Applications
 
 
Clinical Research Informatics (CRI)
 
Clinical Research Informatics (CRI) enables the effective and efficient execution of clinical research -- including clinical trials and outcomes research – by applying the science of information management. The key strategic goal of CRI is to build a world-class clinical research informatics infrastructure by implementing best-in-class vendor solutions where available and developing innovative solutions that give City of Hope researchers a competitive advantage. To advance this goal,CRI led the selection and implementation of the best-in-class Electronic Data Capture (EDC) solution for clinical trials with the Medidata EDC, and deployed the Clinical Research Portal business intelligence solution to help clinical researchers translate their data into decisions.
 
Services
 
  • Clinical Trials Data Capture and Management - Provide informatics solutions to manage the planning, execution, and reporting of clinical trials, such as protocol authoring, adverse event reporting, and subject enrollment
  • Observational Research Data Capture and Management - Provide electronic data capture (EDC) systems with electronic case report forms (eCRFs) or computer-scannable CRFs to capture study data, such as adverse events and tumor response
  • Clinical Research Decision Support - Transforms data into decisions using business intelligence tools to report and analyze study-related data
 
 
Translational Research Informatics Core (TRIC)
 
Translational Research Informatics (TRI) strives to empower ground breaking research from basic bench research to clinical research and back. Our goal is to provide contemporary technological solutions to nimbly and specifically support information capture, management and exchange across the Translational Research Space.
 
Our approach is to provide support and service at the individual lab level. Introducing new information technology solutions to help make gathering and visualization of experimental data more facile and at the same time, to optimize and make the process of scientific research more efficient. While our target clients are in the translational research space, we will develop, in time, an information infrastructure partnered with Clinical Research Informatics (CRI) and Bioinformatics that will spark and enable collaborations across basic and clinical research.
 
Services
 
  • Translational Research Experimental Data Capture, Management and Analyses
  • Systems and Process Analyses for Translational Research
  • Workflow/process analyses, optimization and automation.
  • Integrated inventory and sample management
 
Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media
 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 


NEWS & UPDATES
  • It was 2009 when a City of Hope patient in her 40s learned that the cancer she had been fighting for several years had metastasized to her lungs. Her medical team ran genetic tests on the tumor, but none of the drug therapies available at the time targeted the known mutations in the tumor cells. […]
  • Acute myeloid leukemia (AML) is characterized by a rapidly-developing cancer in the myeloid line of blood cells, which is responsible for producing red blood cells, platelets and several types of white blood cells called granulocytes. Because AML grows rapidly, it can quickly crowd out normal blood cells, leadi...
  • Rachel Divine is a yoga therapist and patient leader for the Sheri & Les Biller Patient and Family Resource Center. She’s also a former City of Hope patient. When someone you know has cancer, even the word “cancer” can make you feel nervous, sleepless, depressed or more. But, as a yoga teacher for 15 ...
  •   Diagnosed with type 1 diabetes when she was 9 years old, Gina Marchini accepted the fact that she would need insulin the rest of her life. Every day, she injected herself with the lifesaving hormone. She also carefully controlled her diet and monitored the rise and fall of her blood glucose with military...
  • The defeat of cancer will require a team effort. Nowhere is this more necessary (or apparent) than in efforts to combat two of the most deadly forms of the disease  – pancreatic cancer and triple-negative breast cancer. It’s the approach City of Hope is taking with its newly launched multidisciplinary teams, br...
  • It’s a reasonable question: Why is the National Cancer Institute funding a study on preventing heart failure? The answer is reasonable as well: Rates of heart failure are drastically high among childhood cancer survivors — 15 times higher than among people the same age who were never treated for cancer. T...
  • Many teenagers take a break from academics during the summer, but not the eight high school students enrolled in the California Institute for Regenerative Medicine (CIRM) Creativity Awards program at City of Hope. They took the opportunity to obtain as much hands-on research experience as possible, learning fro...
  • About one in eight women will develop breast cancer at some point in her life. In fact, breast cancer is the most common cancer in American women, behind skin cancer. Although women can’t change some risk factors, such as genetics and the natural aging process, there are certain things they can do to lower thei...
  • As genetic testing becomes more sophisticated, doctors and their patients are finding that such tests can lead to the discovery of previously unknown cancer risks. In his practice at City of Hope, Thomas Slavin, M.D., an assistant clinical professor in the Division of Clinical Cancer Genetics, sees the full spe...
  • And the winners are … everyone in the San Gabriel Valley. The recipients of City of Hope’s first-ever Healthy Living grants have been announced, and the future is looking healthier already. In selecting San Gabriel Valley organizations to receive the grants, City of Hope’s Community Benefits Advisory Council ch...
  • Barry Leshowitz is a former City of Hope patient and a family advisor for the Sheri & Les Biller Patient and Family Resource Center. It’s been almost seven years since I checked into a local hospital in Phoenix for a hip replacement, only to be informed by the surgeon that he had canceled the surgery....
  • When it comes to science, the best graduate schools don’t just train scientists, they prepare their students for a lifetime of learning, accomplishment and positive impact on society. At City of Hope, the Irell & Manella Graduate School of Biological Sciences goes one step further – by preparing students to...
  • Cancer affects not just the cancer patient, but everyone around him or her, even after treatment is complete. The challenges can include the fear of cancer recurrence, coping with cancer’s economic impact and the struggle to achieve work-life balance post-treatment. Family members and loved ones of cancer patie...
  •   Bladder cancer facts: Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. 2015 estimates: 74,000 new cases of bladder cancer diagnosed 16,000 deaths from bladder cancer (about 11,510 in men and 4,490 in women) Risk factors for bladder cancer: Smoking: Smokers...
  • Women with ovarian cancer have questions about the most promising treatment options, revolutionary research avenues, survivorship and, of course, the potential impact on their personal lives. Now, together in one place, are experts who can provide answers. On Saturday, Sept. 12, the 2015 Ovarian Cancer Survivor...